Market capitalization | $349.75b |
Enterprise Value | $365.21b |
P/E (TTM) P/E ratio | 24.01 |
EV/FCF (TTM) EV/FCF | 17.60 |
EV/Sales (TTM) EV/Sales | 4.16 |
P/S ratio (TTM) P/S ratio | 3.99 |
P/B ratio (TTM) P/B ratio | 4.98 |
Dividend yield | 3.40% |
Last dividend (FY24) | $4.91 |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
24 Analysts have issued a Johnson & Johnson forecast:
24 Analysts have issued a Johnson & Johnson forecast:
Sep '24 |
+/-
%
|
||
Revenue | 87,691 87,691 |
8%
8%
|
|
Gross Profit | 60,217 60,217 |
7%
7%
|
|
EBITDA | 28,858 28,858 |
12%
12%
|
EBIT (Operating Income) EBIT | 21,572 21,572 |
15%
15%
|
Net Profit | 14,684 14,684 |
8%
8%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Head office | United States |
CEO | Joaquin Duato |
Employees | 131,900 |
Founded | 1887 |
Website | www.jnj.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.